Advertisement
Advertisement
HALO
Halozyme Therapeutics, Inc.
130.03
USDSponsored
+1.53
+1.19%
Oct 28, 16:00 UTC -4
Closed
Pre-Market
131.61
+1.58
+1.22%
Halozyme Therapeutics, Inc. (HALO)
Halozyme Therapeutics, Inc. Financial Snapshot
| Market Cap | 14.94B |
| Beta | -- |
| Earnings Per Share (EPS) | 3.35 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 1495.48% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 2.71% |
| Free Cash Flow | 413.06M |
